Trading of the Company's shares of common stock on Nasdaq will be suspended at the open of trading on October 31 CERo plans to appeal the Panel determination, seek trading of its shares on the OTC ...
Cero Generation and Enso Energy aim to build a 1GW solar and storage portfolio in the UK, such as the operational Larks Green project, pictured above. Image: Cero Generation Independent power producer ...
Just hours after news that legendary news broadcaster Bill Moyers had died, the icon was paid tribute at Thursday night’s documentary portion of the National Academy of Television Arts & Sciences’ ...
Investing.com - D. Boral (OTC:BOALY) Capital upgraded Cero Therapeutics (NASDAQ:CERO) from Hold to Buy on Monday, setting a price target of $30.00 based on the company’s innovative approach to T cell ...
CERo Therapeutics Holdings Inc (NASDAQ:CERO) shares are trading higher Tuesday after the company received U.S. Food and Drug Administration (FDA) Orphan Drug Designation for CER-1236. What Happened: ...
Experts have cast doubt on the Trump Organization's claim that its proposed smartphone can be entirely manufactured in the US. One industry analyst told the BBC it would be "virtually impossible" for ...
Whether it was in AAA, CMLL, Lucha Underground, the independent scene, TNA, AEW, or now WWE, there's always been one constant about Penta's career; "Cero Miedo". It's connected to him in a way that ...
CERo Therapeutics Holdings, Inc. announced a one-for-twenty reverse stock split of its common stock, effective at 12:01 a.m. Eastern Time on June 13, 2025. This move will reduce the total outstanding ...
SOUTH SAN FRANSCISCO, Calif., May 30, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc., (Nasdaq: CERO) (“CERo” or the “Company”) an innovative cellular immunotherapy company seeking to ...
Monday, Maxim Group initiated coverage on Cero Therapeutics (NASDAQ: CERO) with a Buy rating and set a price target of $3.00, representing significant upside potential from the current price of $0.60.
SOUTH SAN FRANCISCO, Calif, April 22, 2025 (GLOBE NEWSWIRE) -- CERo Therapeutics Holdings, Inc. (Nasdaq: CERO) (“CERo”), an innovative immunotherapy company seeking to advance the next generation of ...
Have a question about this project? Sign up for a free GitHub account to open an issue and contact its maintainers and the community. Issues are used to track todos, bugs, feature requests, and more.
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback